Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SENS Jan 2022 4.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
1.3500+0.1000 (+8.00%)
As of 11:20AM EDT. Market open.
Advertisement
Full screen
Previous Close1.2500
Open1.4000
Bid1.3000
Ask1.4000
Strike4.00
Expire Date2022-01-21
Day's Range1.3800 - 1.5000
Contract RangeN/A
Volume82
Open Interest11.22k
  • Business Wire

    Senseonics Announces Equity Grants To Employees Under Inducement Plan

    GERMANTOWN, Md., October 04, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan (the "Plan") in accordance with NYSE American Company Guide Section 711(a).

  • Zacks

    Implied Volatility Surging for Senseonics (SENS) Stock Options

    Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

  • Benzinga

    18 Stocks Moving in Tuesday's Pre-Market Session

    Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44 million. Aprea Therapeutics, Inc. (NASDAQ: APRE) rose 15.1% to $5.58 in pre-market trading after the company announced it presented data from the Phase 1/2 trial of eprenetapopt in advanced solid tumors at ESMO Congress 2021. American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) rose 14.1% to $3.23 in pre-market tradin

Advertisement
Advertisement